Cash Equivalents - MedCap AB (publ) (STO:MCAP) - Alpha Spread

MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 493 SEK 2.6% Market Closed
Market Cap: 7.4B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

MedCap AB (publ)
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MedCap AB (publ)
Cash Equivalents Peer Comparison

Comparables:
ALIF B
BICO
BIOT
G
GENO
M
MAGLE

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
MedCap AB (publ)
STO:MCAP
Cash Equivalents
kr262.8m
CAGR 3-Years
24%
CAGR 5-Years
71%
CAGR 10-Years
14%
AddLife AB
STO:ALIF B
Cash Equivalents
kr272m
CAGR 3-Years
8%
CAGR 5-Years
35%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Cash Equivalents
kr861m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Cash Equivalents
kr318m
CAGR 3-Years
5%
CAGR 5-Years
24%
CAGR 10-Years
17%
G
Genovis AB
STO:GENO
Cash Equivalents
kr135.8m
CAGR 3-Years
48%
CAGR 5-Years
72%
CAGR 10-Years
41%
M
Magle Chemoswed Holding AB
STO:MAGLE
Cash Equivalents
kr7.1m
CAGR 3-Years
5%
CAGR 5-Years
26%
CAGR 10-Years
N/A

See Also

What is MedCap AB (publ)'s Cash Equivalents?
Cash Equivalents
262.8m SEK

Based on the financial report for Jun 30, 2024, MedCap AB (publ)'s Cash Equivalents amounts to 262.8m SEK.

What is MedCap AB (publ)'s Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
14%

Over the last year, the Cash Equivalents growth was 18%. The average annual Cash Equivalents growth rates for MedCap AB (publ) have been 24% over the past three years , 71% over the past five years , and 14% over the past ten years .

Back to Top